ArticlePloS one2025
Factors affecting the maximum outcome payments of social impact bonds.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As governments globally seek market-based solutions to address complex social challenges, Social Impact Bonds (SIBs) have gained prominence in public policy reforms for their potential to align fiscal accountability with social innovation. SIBs are innovative financial tools designed to fund social projects through outcome-based payments, lower government financial pressure, and increase the efficiency with which social problems are solved. In a SIB, the maximum outcome payment refers to the highest amount the outcome payer is willing to provide, and is one of the key factors attracting investor participation. It is typically calculated as the sum of service costs and fiscal savings. However, the current approach often prioritizes reducing government expenditure, without sufficiently accounting for the risks and interests of investors. This improper formulation of maximum outcome payments may cause financing bottleneck and hinder the sustainable development of SIBs. To achieve a balance between government cost control and investor returns, this paper systematically examines the key factors influencing maximum outcome payments through multiple regression analysis, with a focus on macroeconomic factors and bond characteristics. The results indicate that maximum outcome payments are correlated with inflation, capital raised, and the size of the target population for the SIB. Therefore, when determining maximum outcome payments, issuers should consider not only fiscal savings but also bond characteristics and macroeconomic factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.